AzTrials
AzTrials

Dental Prosthesis FailureNCT06713577

Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations

An observational study of Dental Prosthesis Failure and Dental Prosthesis Complication, run by Dentsply Sirona Implants and Consumables at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This investigation will be a prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, 3D shaded zirconia material for computer assisted design and computer assisted machining for chairside restorations. The restorations will be evaluated for a period of up to five years. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
What is being tested?
CEREC Cercon 4D
Type of treatment
Medical device
How many people
82 participants
Where
1 siteUnited States
Study dates
3 Dec 2024to 22 Nov 2031
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The patient population will be selected from current patients of either gender and any ethnic background, under clinical treatment at the University of Michigan Dental Clinics.

Who may be able to join

  • Adult aged 18-75 years.
  • Willing and able to sign and date the informed consent form and the HIPAA form.
  • Onlays and Crowns: Each patient should have at least one carious lesion, defective restoration, or fractured portion of the tooth to be restored on a maxillary or mandibular premolar or molar tooth. Each lesion, fracture, or defective restoration should exhibit sufficient size or loss of tooth structure requiring an onlay or crown restoration. The tooth should have at least one opposing tooth in occlusion and one adjacent tooth with an intact proximal contact. No more than eight teeth that are endodontically treated and restorable with an onlay or crown may be included in the study. All remaining teeth in the study will test vital and be asymptomatic at the beginning of treatment. No more than two restorations will be placed per patient. If a patient presents with more than two acceptable teeth for the study, molar teeth will be included prior to premolar teeth.
  • Fixed Partial Dentures (FPDs): Each patient should have at least one missing tooth, either anterior or posterior, that is appropriate for replacement with a fixed partial denture. Abutment teeth will have healthy periodontal status with at least a 1:1 crown:root ratio. The FPD should have at least two opposing teeth in occlusion and one adjacent tooth with an intact proximal contact. Both abutment teeth must be asymptomatic prior to treatment. Endodontically treated teeth will be acceptable for abutments if nonmetallic cores can be placed to retain the FPD. FPDs may include 3 or 4 teeth as indicated by the clinical situation but must be within the 43 mm span of the mill block to manufacture it as described later. The patient cohort should include a mix of non-endodontically as well as endodontically treated teeth.

Who cannot join

  • Unlikely to be able to comply with clinical study procedures, according to Principal Investigator's (PIs) judgment.
  • Subject is not willing to participate in the clinical study.
  • Patients unable to return for the recall appointments for a period of 5 years.
  • Severe non-compliance to the clinical study plan as judged by the PI and/or Dentsply Sirona.
  • Involvement in the planning and conduct of the clinical study. Applies to both Dentsply Sirona personnel and personnel from the clinical study site.
  • Sensitive teeth.
Show all 11Show fewer
  • Teeth diagnosed with symptoms of incomplete tooth fracture.
  • Teeth with a history of direct or indirect pulp capping procedures.
  • Patients with significant untreated dental disease to include periodontitis and/or rampant caries.
  • Women who self-report that they are possibly pregnant, pregnant, or lactating, as elective dental treatment is not indicated at these times.
  • Patients with a self-reported history of allergies to the materials to be used in the study including composite resin cements, provisional acrylics, or zirconia restorative materials.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Department of Cariology, Restorative Sciences, and Endodontics at School of Dentistry

    Ann Arbor, Michigan, 48109-1078

Other trials in United States

About this study

This investigation will be a prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, 3D shaded zirconia material for computer assisted design and computer assisted machining for chairside restorations. The restorations will be evaluated for a period of up to five years. The study is called Clinical Study of a 3D Shaded Zirconia for chairside computer assisted design and computer assisted machining (CAD/CAM) chairside restorations intended to be part of the validation plan and post market follow-up of the following products: CEREC Cercon 4D, Calibra Universal +, and Prime and Bond Active.

Read the detailed description

The primary aim is:

▪ Evaluate the longitudinal clinical performance of 3D shaded zirconia onlays, crowns, and fixed partial denture (FPD) over five years of clinical service. The restorations will be evaluated with modified FDI criteria for maintaining their esthetic, functional and biological properties.

The secondary aims are:

  • Evaluate the resistance to material chipping and fracture of reduced thickness zirconia chairside computer assisted design and computer assisted machining (CAD/CAM) onlays, crowns, and fixed partial dentures (FPDs).
  • Evaluate the short-term post-operative sensitivity associated with cementation techniques using a self-adhesive, universal resin cement and a selective etch/universal bonding agent with a universal resin cement.
Being tested
CEREC Cercon 4D

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CEREC Cercon 4DDevice

    One investigational medical device is a new generation of a full contour zirconia restorative material (CEREC Cercon 4D/Dentsply Sirona) for chairside computer assisted design/computer assisted machines (CAD/CAM) restorations. It has an internal core of 4 mol% (4Y) zirconia transitioning to an external layer of 4/5 mol% (4/5 Y) zirconia with a three-dimensional gradient of shade from an inner chromatic layer to an external translucent layer that replicates the natural structure and appearance of a tooth. It is indicated for crowns, bridges, veneers, inlays and onlays and implant crowns Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations The other investigational medical devices are a universal bonding agent (Prime and Bond Active/Dentsply Sirona) and dual-cure, self-adhesive resin cement (Calibra Universal

    +/Dentsply Sirona). They are used in combination to deliver ceramic and zirconia restorations.

Study groups in NCT06713577
Study groupRoleWhat they receive
Group 1 Crowns35 crowns delivered with a universal resin cement (Calibra Universal + by Dentsply Sirona).
Receives: Device: CEREC Cercon 4D
Group 2 Onlays35 onlays delivered with selective enamel etch, bonding agent, and universal resin cement (Prime \& Bond Active with Calibra Universal + by Dentsply Sirona).
Receives: Device: CEREC Cercon 4D
Group 3 Fixed Partial Dentures (FPD)12 Fixed Partial Dentures (FPD) delivered with a universal resin cement (Calibra Universal + by Dentsply Sirona).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.

    The restorations will be evaluated according to the modified World Dental Federation notation (FDI) criteria for maintaining their esthetic functional and biological properties.

    Measured: At the five year follow up

Secondary outcomes (3)
  1. Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs.

    The restorations will be evaluated according to the modified World Dental Federation notation criteria (FDI) for maintaining their esthetic functional and biological properties.

    Measured: At the 6 month, 1 year, 2 year, 3 year and 4 year follow up

  2. Evaluation of the resistance of the material chipping and fracture of the reduce thickness zirconia CAD/CAM onlays, crowns and FPDs.

    The restorations will be evaluated according to the modified World Dental Federation notation (FDI) criteria for maintaining their esthetic functional and biological properties.

    Measured: At the 6 month, 1 year, 2 year, 3 year and 4 year and 5 year follow up.

  3. Evaluation of the short-term post operative sensitivity associated with cementation techniques using a self-adhesive, universal resin cement and a selective etch/universal bonding agent with a universal resin cement.

    A criterion-referenced rating scale will be used to measure sensitivity (Scores 1-4)

    Sensitivity:

    1. = No sensitivity is experienced at anytime
    2. = Slight sensitivity is experienced occasionally but it is not uncomfortable
    3. = Moderate sensitivity is experienced intermittently, and it is noticeably uncomfortable
    4. = Severe discomfort is noted routinely with cold or pressure stimulation

    Measured: Once a week after base line up to four weeks or until patient is asymptomatic.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2024
  2. Study start3 Dec 2024
  3. Primary completion22 Jan 2031 (estimated)
  4. Study completion22 Nov 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
82 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06713577
Sponsor's protocol ID
C-RE-24-018
Other IDs
HUM00263115
Status last verified
Mar 2026
First submitted
27 Nov 2024
Last updated
9 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Dental Prosthesis Failure and Dental Prosthesis Complication, run by Dentsply Sirona Implants and Consumables at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluation of the longitudinal clinical performance of 3D shaded zirconia onlays, crowns and FPDs. (time frame: At the five year follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in